crime

New drugs fuel strong Pfizer results; company raises 2016 forecasts

Pfizer said sales would be hurt in the fourth quarter of 2016, however, when those added days will be offset by fewer days. Pfizer walked away from the deal after the U.S. Treasury issued new rules curbing tax inversion deals, under which American companies move overseas to cut taxes. Many analysts believe Pfizer needs to buy new medicines or entire biotech companies to ensure competitive earnings growth.

Read more here:
New drugs fuel strong Pfizer results; company raises 2016 forecasts

crime

U.S. prosecutors consider more charges against ex-CEO Shkreli

NEW YORK (Reuters) – Former drug executive Martin Shkreli, who last year became a lightning rod for outrage over soaring prescription drug prices, may face additional U.S. charges of securities fraud, a federal prosecutor

Read more from the original source: 
U.S. prosecutors consider more charges against ex-CEO Shkreli

crime

Ex-Goldman Sachs employee spared jail over New York Fed leaks

A former Goldman Sachs Group Inc associate who admitted to illegally obtaining confidential documents from a friend at the Federal Reserve Bank of New York was handed a fine on Tuesday but…

Here is the original post:
Ex-Goldman Sachs employee spared jail over New York Fed leaks

crime

Smirking Shkreli refuses lawmakers’ questions, calls them ‘imbeciles’

By Sarah N. Lynch and David Ingram WASHINGTON/NEW YORK (Reuters) – Former drug executive Martin Shkreli smirked and brushed off questions about drug prices then tweeted that lawmakers were imbeciles on Thursday, when he appeared at a U.S. congressional hearing against his will. Shkreli, 32, sparked outrage last year among patients, medical societies and Democratic presidential front-runner Hillary Clinton after his company, Turing Pharmaceuticals, raised the price of the drug Daraprim by more than 5,000 percent to $750 a pill. At a hearing of the U.S. House…

Read the rest here: 
Smirking Shkreli refuses lawmakers’ questions, calls them ‘imbeciles’

crime

Smirking Shkreli refuses lawmakers’ questions, calls them ‘imbeciles’

By Sarah N. Lynch and David Ingram WASHINGTON/NEW YORK (Reuters) – Former drug executive Martin Shkreli smirked and brushed off questions about drug prices then tweeted that lawmakers were imbeciles on Thursday, when he appeared at a U.S. congressional hearing against his will. Shkreli, 32, sparked outrage last year among patients, medical societies and Democratic presidential front-runner Hillary Clinton after his company, Turing Pharmaceuticals, raised the …

See more here:
Smirking Shkreli refuses lawmakers’ questions, calls them ‘imbeciles’

crime

AmEx to cut $1 billion in costs by end of 2017

(Reuters) – Credit card issuer American Express Co said it would cut $1 billion in costs by the end of 2017 as it responds to intensifying competition in the payments industry. AmEx's shares fell 4.1 percent to $60.05 in extended trading on Thursday, after the company reported its fourth straight decline in

More here: 
AmEx to cut $1 billion in costs by end of 2017

crime

Boeing to cut 747-8 production in half as demand slows

Boeing Co said on Thursday it will cut production of its 747-8 jumbo jet in half and take a $569 million charge in the fourth quarter as it faces dwindling sales. “The air cargo market recovery that began in late 2013 has stalled in recent months and slowed demand for the 747-8 freighter,” Ray Conner, chief executive of Boeing Commercial Airplanes, said in a statement. Boeing has disclosed in its regulatory filings for months that the costs of making the…

See the original post here:
Boeing to cut 747-8 production in half as demand slows

crime

Yahoo to decide next strategic steps after quarterly earnings: sources

Yahoo Inc will decide on its next strategic steps only after releasing quarterly earnings on Feb. 2, people familiar with the matter said, as the company continues to resist investor calls to explore a sale of its core Internet assets. Yahoo wants to gauge shareholder reaction after presenting its strategic vision during the earnings conference call, one of the people said. Yahoo this month rebuffed several potential buyers for its core Internet assets, including private equity firms, the three sources said this week.

Continued here: 
Yahoo to decide next strategic steps after quarterly earnings: sources

crime

Drug exec Shkreli, lawmakers clash ahead of congressional hearing

Former pharmaceutical executive Martin Shkreli was on a collision course with Congress on Thursday as lawmakers warned he could be prosecuted for contempt if he does not appear next week for a hearing about drug prices. A lawyer for Shkreli…

Go here to see the original:
Drug exec Shkreli, lawmakers clash ahead of congressional hearing

crime

Turing Pharma names chairman to replace Shkreli as CEO

(Reuters) – Martin Shkreli, the poster boy for prescription drug price increases who was arrested for securities fraud this week, has stepped down from his post as chief executive officer of Turing Pharmaceuticals Inc, the company said on Friday. Shkreli was replaced by Turing Chairman Ron Tilles, who said in a statement that the company was committed to continuing…

View original post here:
Turing Pharma names chairman to replace Shkreli as CEO

Next Page »